Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

Immunodominant T cell epitopes of myelin basic protein (MBP) may be target antigens for major histocompatibility complex class II- restricted, autoreactive T cells in multiple sclerosis (MS). Since susceptibility to MS is associated with the DR2 haplotype, the binding and presentation of the immunodominant MBP(84-102) peptide by DR2 antigens were examined. The immunodominant MBP(84-102) peptide was found to bind with high affinity to DRB1*1501 and DRB5*0101 molecules of the disease-associated DR2 haplotype. Overlapping but distinct peptide segments were critical for binding to these molecules; hydrophobic residues (Val189 and Phe92) in the MBP(88-95) segment were critical for peptide binding to DRB1*1501 molecules, whereas hydrophobic and charged residues (Phe92, Lys93) in the MBP(89-101/102) sequence contributed to DRB5*0101 binding. The different registers for peptide binding made different peptide side chains available for interaction with the T cell receptor. Although the peptide was bound with high affinity by both DRB1 and DRB5 molecules, only DRB1 (DRB1*1501 and 1602) but not DRB5 molecules served as restriction elements for a panel of T cell clones generated from two MS patients suggesting that the complex of MBP(84-102) and DRB1 molecules is more immunogenic for MBP reactive T cells. The minimal MBP peptide epitope for several T cell clones and the residues important for binding to DRB1*1501 molecules and for T cell stimulation have been defined.

[1]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[2]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[3]  E. Unanue,et al.  Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope , 1987, Nature.

[4]  J. Todd,et al.  A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.

[5]  Charles A. Janeway,et al.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs , 1992, Nature.

[6]  D. McFarlin,et al.  Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice , 1984, Nature.

[7]  J. Rothbard,et al.  Conformational and structural characteristics of peptides binding to HLA-DR molecules. , 1991, Journal of immunology.

[8]  A Sette,et al.  Truncation analysis of several DR binding epitopes. , 1991, Journal of immunology.

[9]  E. D. Robinson,et al.  Human cytotoxic T‐cell recognition of a synthetic peptide of myelin basic protein , 1989, Annals of neurology.

[10]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[11]  J. Satoh.  Experimental allergic encephalomyelitis mediated by murine encephalitogenic T-cell lines specific for myelin proteolipid apoprotein , 1987, Journal of Neuroimmunology.

[12]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[13]  Lawrence Steinman,et al.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy , 1989, Cell.

[14]  T. Olsson,et al.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Sidney,et al.  DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. , 1992, Journal of immunology.

[16]  J G Bodmer,et al.  HLA CLASS II NUCLEOTIDE SEQUENCES, 1991 , 1991, Human immunology.

[17]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[18]  Eric O Long,et al.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis , 1991, The Journal of experimental medicine.

[19]  A. Trzeciak,et al.  A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules , 1988, Nature.

[20]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[21]  C Oseroff,et al.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. , 1991, Journal of immunology.

[22]  J. Drijfhout,et al.  Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. , 1992, Journal of immunology.

[23]  William S. Lane,et al.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.

[24]  E. D. Robinson,et al.  Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. , 1992, Journal of immunology.

[25]  J. Strominger,et al.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. , 1987, The Journal of biological chemistry.

[26]  F. Sinigaglia,et al.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.

[27]  H. Weiner,et al.  T-cell recognition of myelin basic protein. , 1991, Immunology today.

[28]  L. Kappos,et al.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Knobler,et al.  T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination , 1985, Nature.

[30]  J. Rothbard,et al.  Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. , 1991, Journal of immunology.

[31]  H. Grey,et al.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Wiley,et al.  Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.

[33]  R. Spielman,et al.  The genetics of susceptibility to multiple sclerosis. , 1982, Epidemiologic reviews.

[34]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[35]  Eric O Long,et al.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.

[36]  D. Bourdette,et al.  Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules , 1989, Journal of neuroscience research.

[37]  O. Rötzschke,et al.  Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. , 1991, Immunology today.